Wolverine Asset Management’s Standard BioTools LAB Stock Holding History

Wolverine Asset Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000	Closed	-$1K	–	2444
2022 Q2	$1K	Hold	1,000	–	–	﹤0.01%	2281
2022 Q1	$3K	Hold	1,000	–	–	﹤0.01%	2049
2021 Q4	$3K	Hold	1,000	–	–	﹤0.01%	1961
2021 Q3	$6K	Hold	1,000	–	–	﹤0.01%	1823
2021 Q2	$6K	Hold	1,000	–	–	﹤0.01%	2046
2021 Q1	$4K	Sell	1,000 -2,000	-67%	-$11K	﹤0.01%	1937
2020 Q4	$18K	Buy	+3,000	New	+$19.7K	﹤0.01%	1450
2017 Q4	–	Sell	-300	Closed	-$1K	–	1528
2017 Q3	$1K	Sell	300 -14,700	-98%	-$61.8K	﹤0.01%	1318
2017 Q2	$60K	Sell	15,000 -6,500	-30%	-$30.8K	﹤0.01%	1105
2017 Q1	$122K	Buy	21,500 +14,100	+191%	+$89.3K	﹤0.01%	921
2016 Q4	$53K	Sell	7,400 -18,800	-72%	-$118K	﹤0.01%	1001
2016 Q3	$209K	Buy	26,200 +8,400	+47%	+$77.1K	﹤0.01%	863
2016 Q2	$160K	Buy	17,800 +17,615	+9,522%	+$166K	﹤0.01%	910
2016 Q1	$14K	Sell	185 -335	-64%	-$2.42K	﹤0.01%	1030
2015 Q4	$48K	Buy	520 +424	+442%	+$4.16K	﹤0.01%	1151
2015 Q3	$15K	Buy	+96	New	+$1.51K	﹤0.01%	1513

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Wolverine Asset Management's LAB Position: Q2 2024 in Review

Wolverine Asset Management sold out of Standard BioTools (LAB) in Q2 2024, closing a stake of 100 shares — an estimated $271 sold.

Wolverine Asset Management first reported a position in LAB in Q3 2017 and held it in 3 quarters. The position peaked at $271 in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2024.

Wolverine Asset Management reported no remaining Standard BioTools position as of Q2 2024 after selling out during the quarter.
Wolverine Asset Management sold 100 Standard BioTools shares in Q2 2024, an estimated $271.
Wolverine Asset Management first reported a position in Standard BioTools in Q3 2017 and held it in 3 quarters.
Wolverine Asset Management's Standard BioTools position peaked at $271 in Q1 2024.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.